Maura L. Gillison
Affiliations: | Johns Hopkins University, Baltimore, MD |
Area:
Public HealthGoogle:
"Maura Gillison"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gharzai LA, Morris E, Suresh K, et al. (2024) Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis. The Lancet. Oncology. 25: 366-375 |
D'Souza G, Tewari SR, Troy T, et al. (2024) Oncogenic Oral Human Papillomavirus Clearance Patterns Over 10 years. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology |
Chaturvedi AK, Engels EA, Pfeiffer RM, et al. (2023) Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 41: 3081-3088 |
Gillison ML. (2023) Flashback Foreword: Human Papillomavirus and Incidence and Survival of Oropharyngeal Cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 41: 3079-3080 |
Akagi K, Symer DE, Mahmoud M, et al. (2023) Intratumoral heterogeneity and clonal evolution induced by HPV integration. Cancer Discovery |
Landy R, Haber G, Graubard BI, et al. (2023) Upper age-limits for US male HPV-vaccination for oropharyngeal cancer prevention: A microsimulation-based modeling study. Journal of the National Cancer Institute |
Caudell JJ, Gillison ML, Maghami E, et al. (2022) NCCN GuidelinesĀ® Insights: Head and Neck Cancers, Version 1.2022. Journal of the National Comprehensive Cancer Network : Jnccn. 20: 224-234 |
Symer DE, Akagi K, Geiger HM, et al. (2021) Diverse tumorigenic consequences of human papillomavirus integration in primary oropharyngeal cancers. Genome Research |
Bigelow EO, Harris J, Fakhry C, et al. (2021) Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: A secondary analysis of NRG Oncology RTOG 0129 and 0522. Head & Neck |
Ferris RL, Flamand Y, Weinstein GS, et al. (2021) Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101752 |